Technical Analysis for GUTS - Fractyl Health, Inc.

Grade Last Price % Change Price Change
D 7.06 5.53% 0.37
GUTS closed up 5.53 percent on Friday, May 17, 2024, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Fell Below 50 DMA Bearish 5.53%
New Uptrend Bullish 5.53%
Upper Bollinger Band Touch Strength 5.53%
20 DMA Support Bullish -1.26%

   Recent Intraday Alerts

Alert Time
10 DMA Support 1 day ago
1.5x Volume Pace 1 day ago
Fell Below 20 DMA 1 day ago
20 DMA Support 1 day ago
Down 3% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fractyl Health, Inc. Description

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Diabetes Gene Therapy Obesity

Is GUTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.5
52 Week Low 5.7501
Average Volume 260,896
200-Day Moving Average 0.00
50-Day Moving Average 6.88
20-Day Moving Average 6.55
10-Day Moving Average 6.48
Average True Range 0.53
RSI (14) 54.75
ADX 28.22
+DI 17.02
-DI 19.15
Chandelier Exit (Long, 3 ATRs) 5.69
Chandelier Exit (Short, 3 ATRs) 7.59
Upper Bollinger Bands 7.15
Lower Bollinger Band 5.96
Percent B (%b) 0.93
BandWidth 18.21
MACD Line -0.08
MACD Signal Line -0.19
MACD Histogram 0.1074
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.37
Resistance 3 (R3) 8.29 7.79 8.15
Resistance 2 (R2) 7.79 7.45 7.82 8.07
Resistance 1 (R1) 7.42 7.25 7.61 7.50 8.00
Pivot Point 6.92 6.92 7.01 6.95 6.92
Support 1 (S1) 6.55 6.58 6.74 6.63 6.12
Support 2 (S2) 6.05 6.38 6.08 6.05
Support 3 (S3) 5.68 6.05 5.97
Support 4 (S4) 5.76